A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to examine the efficacy and safety of once-weekly LY2189265
(dulaglutide) in participants with type 2 diabetes mellitus taking an oral antihyperglycemic
medication (OAM).